HK135494A - Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient - Google Patents
Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredientInfo
- Publication number
- HK135494A HK135494A HK135494A HK135494A HK135494A HK 135494 A HK135494 A HK 135494A HK 135494 A HK135494 A HK 135494A HK 135494 A HK135494 A HK 135494A HK 135494 A HK135494 A HK 135494A
- Authority
- HK
- Hong Kong
- Prior art keywords
- embonate
- azelastin
- active ingredient
- pharmaceutical compositions
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE3738641 | 1987-11-13 | ||
| SG153894A SG153894G (en) | 1987-11-13 | 1994-10-21 | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK135494A true HK135494A (en) | 1994-12-09 |
Family
ID=25861795
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK135494A HK135494A (en) | 1987-11-13 | 1994-12-01 | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0316639B1 (xx) |
| JP (1) | JP2730581B2 (xx) |
| AT (1) | ATE106883T1 (xx) |
| CA (1) | CA1317595C (xx) |
| DE (1) | DE3850044D1 (xx) |
| DK (1) | DK170339B1 (xx) |
| ES (1) | ES2053679T3 (xx) |
| HK (1) | HK135494A (xx) |
| SG (1) | SG153894G (xx) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4013696A1 (de) * | 1989-05-05 | 1990-11-08 | Asta Pharma Ag | Salze des azelastins mit verbesserter loeslichkeit |
| JPH04198180A (ja) * | 1990-11-28 | 1992-07-17 | Eezai Kagaku Kk | ベンジルフタラゾン誘導体の製造方法 |
| US20070020330A1 (en) | 2004-11-24 | 2007-01-25 | Medpointe Healthcare Inc. | Compositions comprising azelastine and methods of use thereof |
| US8758816B2 (en) | 2004-11-24 | 2014-06-24 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
| EP2486942B1 (en) | 2004-11-24 | 2018-10-10 | Meda Pharmaceuticals Inc. | Compositions comprising azelastine and methods of use thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH572914A5 (xx) * | 1971-01-22 | 1976-02-27 | Asta Werke Ag Chem Fab |
-
1988
- 1988-10-28 ES ES88117969T patent/ES2053679T3/es not_active Expired - Lifetime
- 1988-10-28 EP EP88117969A patent/EP0316639B1/de not_active Expired - Lifetime
- 1988-10-28 AT AT88117969T patent/ATE106883T1/de not_active IP Right Cessation
- 1988-10-28 DE DE3850044T patent/DE3850044D1/de not_active Expired - Lifetime
- 1988-11-10 CA CA000582812A patent/CA1317595C/en not_active Expired - Lifetime
- 1988-11-11 DK DK630088A patent/DK170339B1/da not_active IP Right Cessation
- 1988-11-14 JP JP63285946A patent/JP2730581B2/ja not_active Expired - Lifetime
-
1994
- 1994-10-21 SG SG153894A patent/SG153894G/en unknown
- 1994-12-01 HK HK135494A patent/HK135494A/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JPH01153686A (ja) | 1989-06-15 |
| DK170339B1 (da) | 1995-08-07 |
| DE3850044D1 (de) | 1994-07-14 |
| SG153894G (en) | 1995-03-17 |
| EP0316639B1 (de) | 1994-06-08 |
| CA1317595C (en) | 1993-05-11 |
| ATE106883T1 (de) | 1994-06-15 |
| DK630088A (da) | 1989-05-14 |
| EP0316639A2 (de) | 1989-05-24 |
| ES2053679T3 (es) | 1994-08-01 |
| DK630088D0 (da) | 1988-11-11 |
| EP0316639A3 (en) | 1990-07-18 |
| JP2730581B2 (ja) | 1998-03-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW272195B (xx) | ||
| UA32512C2 (uk) | Похідні ксантину, спосіб їх одержання, та фармацевтична композиція | |
| IL84446A0 (en) | 3-pyrrolidinylthio-1-azabicyclo-(3.2.0)hept-2-ene-2-carboxylic acid derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| GR3007385T3 (xx) | ||
| IL101358A0 (en) | Crystalline tiagabine hydrochloride monohydrate,its preparation and pharmaceutical compositions containing it | |
| EP0293751A3 (en) | Taurohyodeoxycholic acid for the therapy of calculosis of the biliary tract and of biliary dyspepsia | |
| IL85189A (en) | Beta-alkyl substituted melatonins,their preparation and pharmaceutical compositions containing them | |
| DE59001121D1 (en) | Antacidatabletten. | |
| EP0316639A3 (en) | Azelastin embonate, process for its preparation and pharmaceutical compositions containing azelastin embonate as the active ingredient | |
| IL61989A (en) | 1-(1,3,4-oxadiazolyl-phenoxy)-3-(phenylpiperazino)propan-2-ols and their derivatives,their preparation and pharmaceutical compositions containing them | |
| TW218011B (xx) | ||
| AU8452891A (en) | Calcium uptake inhibitors | |
| IE883402L (en) | Azelastine embonate, processes for its preparation and pharmaceutical formulations which contain azelastine embonate as active substance | |
| UA32583C2 (uk) | Похідні арилтіоалкілтіопіридину | |
| AU1621888A (en) | Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes | |
| JO1531B1 (en) | New near-compounds | |
| JO1843B1 (en) | Benzimercool vehicles carry alternatives and processes for their preparation and use in a pharmacy | |
| JO1519B1 (en) | New compounds (new benzimidazole derivatives are effective as ulcers) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PF | Patent in force | ||
| CHPA | Change of a particular in the register (except of change of ownership) | ||
| PE | Patent expired |
Effective date: 20081027 |